Otis Brunson
Medical Oncology · Jackson, MSNPI 1356838783
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.2% of the total across 128 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,046 and has fallen 83.6% since, to $172 in 2025. That places this record below the midpoint for medical oncology clinicians in MS, where the typical reported total is $7,285.
Across 128 payments — averaging $20.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$416
- Takeda Pharmaceuticals U.S.A., Inc.$351
- Seagen Inc.$206
- Astellas Pharma US Inc$205
- AstraZeneca$181
- Sanofi$143
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,45992%
- Education$2078%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 23 | $416 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $351 |
| Seagen Inc. | 5 | $206 |
| Astellas Pharma US Inc | 9 | $205 |
| AstraZeneca | 6 | $181 |
| Sanofi | 7 | $143 |
| Merck | 7 | $122 |
| Bristol Myers Squibb | 5 | $115 |
| Johnson & Johnson | 5 | $111 |
| Novartis | 5 | $102 |
| E.r. Squibb & Sons, L.L.C. | 5 | $78 |
| EMD Serono, Inc. | 4 | $66 |
| Pfizer | 4 | $65 |
| ADC Therapeutics America, Inc. | 3 | $59 |
| Amgen | 4 | $59 |
| Puma Biotechnology, Inc. | 3 | $52 |
| Springworks Therapeutics, Inc. | 3 | $50 |
| Karyopharm Therapeutics Inc. | 3 | $49 |
| Recordati_rare_diseases_inc. | 2 | $34 |
| Exelixis Inc. | 1 | $27 |
| AbbVie | 1 | $26 |
| Immunocore Limited | 1 | $25 |
| Lilly USA, LLC | 1 | $21 |
| AVEO Pharmaceuticals, Inc. | 1 | $19 |
| Genmab U.S., Inc. | 1 | $17 |
| Deciphera Pharmaceuticals Inc. | 1 | $16 |
| BD | 1 | $15 |
| Rigel Pharmaceuticals, Inc. | 1 | $13 |
| Apellis Pharmaceuticals, Inc. | 1 | $13 |
| Secura Bio, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ICLUSIG$125
How this compares
$2,665 in reported general payments places this provider in the 25th percentile of 20 medical oncology providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IbrancePalbociclib | 12 | $187,953 |
| ValacyclovirValacyclovir Hcl | 12 | $587 |
| Gabapentin | 14 | $130 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerIbrance | $65 | $187,95312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 20 medical oncology providers in Mississippi.
Other medical oncology in Jackson
- James ThigpenJackson$41K
- Tammy YoungJackson$12K
- Elizabeth HerringtonJackson$10K
- Manubhai PatelJackson$7K
- Robert HamiltonJackson$6K
- Nicole ClevelandJackson$6K
- Louis PunekyJackson$5K
- Natale SheehanJackson$4K
- John RuckdeschelJackson$2K
- Ralph VanceJackson$173
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.